Giacobini, M., Medin, E., Ahnemark, E., Russo, L.J. and Carlqvist, P. (2018) Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed with ADHD in Sweden. Journal of Attention Disorders, 22, 3-13.
https://doi.org/10.1177/1087054714554617

has been cited by the following article:

• TITLE: ADHD in Children and Adolescents: Barriers to Ethical and Successful Treatment

  AUTHORS: Katherine T. Smith

  KEYWORDS: ADHD, Neurodevelopmental Disorder, Medication Safety, Socioeconomic, Attention Deficit Hyperactivity Disorder

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.3, March 10, 2023

  ABSTRACT: This review provides a comprehensive analysis of attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder characterized by inattention, hyperactivity, or impulsivity. The global prevalence of the disorder ranges from 2% to 7%, with an average of around 5%. ADHD affects individuals of all ages, with symptoms typically becoming visible as early as 3 years. The symptoms range from mild to severe and may persist into adulthood. The disorder affects a variety of demographic groups, including differences in age, gender, race, and ethnicity, with varying effects, prevalence, and treatment options among these groups. Treatment options for ADHD range from behavioral interventions to prescription medication, with a number of medications available on the market for treating ADHD. The review also highlights the issues of relapse and safety concerns associated with the use of medication, as well as the challenges associated with diversity and socioeconomic barriers in the diagnosis and treatment of the disorder.